Congress must pass the PASTEUR Act to create a more sustainable environment for antimicrobial R & D and ensure a robust pipeline for future treatments. Click here to learn how AMR threatens NJ's patients and what can be done to address these issues. https://t.co/6Tm55COg3g
150+ healthcare providers, public health experts, scientists, patient advocacy groups, and the pharmaceutical and diagnostics industries, signed a letter urging Congress address the growing crisis of antimicrobial resistance (AMR) and pass the PASTEUR Act. https://t.co/VNzYQNQEn2
Stop by the Mayors Information Center #njleague for refreshments on the @mayorscommlfsci and join us for a cocktail at Carmine’s Bar in the Tropicana at 5:30!
Improving drug affordability is a top priority for patients who rely on prescription medicine. While we support efforts to improve infrastructure, forgoing the rebate rule to fund them will do nothing to lower costs for patients. @SenatorMenendez, please find a better option!
Amid #Covid19, we should be supporting economic growth and recovery. But #HR3 would do the opposite - crushing New Jersey’s biopharmaceutical ecosystem while stifling innovation with #pricecontrols
Great advice from our Senator @CoryBooker! To find out more about how you can get vaccinated, visit NJ’s Covid-19 information hub at https://t.co/kTMGA9cZHX
Get vaccinated for your community.
Get vaccinated to put kids back in school.
Get vaccinated for first responders.
Get vaccinated to see your grandparents.
Get vaccinated.
Celebrate women and girls in science! Join us on Facebook Live for a Q&A with Clinton Mayor @janicekovach and Newark scientist Denarra Simmons. Plus, a message from @SenBooker. Wednesday 3/3 at 12pm ET https://t.co/g6z2avjGtC
Under the administration’s new #MFN rule, everyone loses. Healthcare businesses will be hurt financially, fewer new treatments will be produced, and patients will suffer the consequences. Learn more about the dangers of government price fixing: https://t.co/XWZJC1c9eg
The Trump Administration’s new #MostFavoredNation rule deprives the #healthcare industry of the resources it needs for the innovation of new medicines and leads to worse outcomes for #patients.
As COVID-19 cases continue to rise, the United States should not jeopardize the healthcare industry’s drug innovation pipeline or patients access to needed medicines with the new Most Favored Nations rule, a foreign #referencepricing scheme that replaces free markets.
During the #COVID19#pandemic, Americans are relying even more on biopharmaceutical companies to develop life-saving medications and vaccines. @realDonaldTrump’s #MFN rule will jeopardize that process. #RejectMFN
It’s simple. #ScienceWorks. And when we trust in science, we all win. Meet Adriana Tovar-Salazar. She's a biochemist in Seattle, Washington making the world a better place through cutting-edge cancer research. This is her story. https://t.co/Om4M0TXI1D
Thanks to .@RepBonnie for her leadership in DC + efforts in #NJ12 during the #COVID19 pandemic. As the state re-opens, here's a resource that can help those with underlying issues stay healthy. Please share! https://t.co/gVE4mWvXRs
Thanks to .@RepJoshG for his leadership in DC + efforts in #NJ5 during the #COVID19 pandemic. As the state re-opens, here's a resource that can help those with underlying issues stay healthy. Please share! https://t.co/gVE4mWvXRs
Thanks to .@SenatorMenendez for his leadership in DC + efforts in NJ during the #COVID19 pandemic. As the state re-opens, here's a resource that can help those with underlying issues stay healthy. Please share! https://t.co/gVE4mWvXRs